S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
OTCMKTS:OPYGY

Public Joint Stock Company Polyus (OPYGY) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free OPYGY Stock Alerts
$21.00
0.00 (0.00%)
(As of 10/3/2023)
Compare
Today's Range
$21.00
▼
$21.00
50-Day Range
$21.00
▼
$21.00
52-Week Range
$18.55
▼
$123.00
Volume
N/A
Average Volume
10,863 shs
Market Capitalization
N/A
P/E Ratio
235.73
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
OPYGY stock logo

About Public Joint Stock Company Polyus Stock (OTCMKTS:OPYGY)

Public Joint Stock Company Polyus, together with its subsidiaries, engages in the extraction, refining, and sale of gold. The company has primary operations in Krasnoyarsk, Irkutsk, and Magadan regions, as well as the Republic of Sakha in Russia. It also engages in the research and exploration works. The company was incorporated in 2006 and is based in Moscow, Russia.

OPYGY Stock Price History

OPYGY Stock News Headlines

April 16, 2024 | finance.yahoo.com
Public Joint Stock Company Gazprom (GAZP.ME)
January 30, 2024 | uk.finance.yahoo.com
Public Joint Stock Company Polyus (PLZL.ME)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
January 19, 2024 | morningstar.com
Vinaconex Trading And Manpower Joint Stock Company
October 13, 2023 | sg.finance.yahoo.com
Mobile TeleSystems Public Joint Stock Company (MBT.BA)
June 21, 2023 | finance.yahoo.com
VTBR.ME - VTB Bank (public joint-stock company)
April 9, 2023 | forbes.com
Public Bank
March 30, 2023 | ca.finance.yahoo.com
Public Joint Stock Company ALROSA (ALRS.ME)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 9, 2023 | thestreet.com
Why PETA Buys Stock in Companies it Protests
February 2, 2023 | finance.yahoo.com
AM Best Revises Outlooks to Negative for Post-Telecommunication Joint Stock Insurance Corporation
December 29, 2022 | benzinga.com
Coya Therapeutics, Inc. Announces Pricing of $15.25 Million Initial Public Offering
November 29, 2022 | finance.yahoo.com
Russian Gold Billionaire to Face New Probe in France Over Luxury Villas
November 16, 2022 | seekingalpha.com
Graphex Group stock jumps 24% amid filing related to graphite processing JV
September 23, 2022 | reuters.com
PLZL.MM - Polyus PJSC | Stock Price & Latest News | Reuters
September 21, 2022 | markets.businessinsider.com
Polyus Gold earnings: here's what to expect
September 21, 2022 | marketwatch.com
Polyus 1H Gold Output Hit by Lower Production, Grades -- Commodity Comment
September 11, 2022 | reuters.com
VCB.HM - Joint Stk Com Bk for Foreign Trade Vt nm | Stock Price & Latest News | Reuters
September 9, 2022 | reuters.com
Military Commercial Joint Stock Bank
August 16, 2022 | money.usnews.com
Russia's Polyus Plans Bond Issue Denominated in Yuan - Interfax
August 9, 2022 | apnews.com
Poseida Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 2, 2022 | investopedia.com
Pfizer to Sell Stake in Its Consumer Healthcare Joint Venture with GSK
May 20, 2022 | finance.yahoo.com
Payouts From Top Russian Gold Miner to Fund Islamic Charity After Sanctioned Billionaire Exits
April 6, 2022 | finance.yahoo.com
Sanctioned Russian’s Family Sells $6 Billion Stake in Gold Miner
November 25, 2021 | markets.businessinsider.com
Polyus Gold PJSC (spons ADRs) earnings preview: what Wall Street is expecting
October 23, 2021 | investing.com
Polyus PAO ADR (OPYGY)
August 24, 2021 | markets.businessinsider.com
Polyus Gold PJSC (spons ADRs) is about to announce its earnings — here's what to expect
See More Headlines
Receive OPYGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Public Joint Stock Company Polyus and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Basic Materials
Industry
Gold
Sub-Industry
N/A
Current Symbol
OTCMKTS:OPYGY
CUSIP
N/A
CIK
N/A
Web
polyus.com
Phone
(495) 641-3377
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
235.73
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover
10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Vladimir Anatolyevich Polin (Age 61)
    Chairman & SVP of Operations
  • Mr. Alexey Alesksandrovich Vostokov
    CEO & Director
  • S. I. Kosarev
    Director of Accounting & Financial Reporting
  • Mr. Andrey Mikhaylovich Krylov (Age 48)
    VP of Operations & Technical Devel.
  • Mr. Stanislav Pisarenko
    VP of Legal & Property Affairs and Director
  • Ms. Julia Andronovskaya
    VP of HR & Organizational Devel. and Director
  • Mr. Alexander Kruchinin (Age 46)
    VP of Health, Safety, Environment & Sustainability
  • Ms. Anna Olegovna Solotova
    Corp. Sec.
  • Mr. Anton Borisovich Rumyantsev
    Director

Key Competitors

View All Competitors

OPYGY Stock Analysis - Frequently Asked Questions

How have OPYGY shares performed in 2024?

Public Joint Stock Company Polyus' stock was trading at $21.00 on January 1st, 2024. Since then, OPYGY shares have increased by 0.0% and is now trading at $21.00.
View the best growth stocks for 2024 here.

Is Public Joint Stock Company Polyus a good dividend stock?

Public Joint Stock Company Polyus (OTCMKTS:OPYGY) pays an annual dividend of $1.62 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 1,818.51%. Payout ratios above 75% are not desirable because they may not be sustainable.

How do I buy shares of Public Joint Stock Company Polyus?

Shares of OPYGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OPYGY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media